Tag: AngioSafe

AngioSafe Unveils Atheroplasty Innovation Following FDA 510(k) Clearance, CE Mark Approval, and First Real-World Procedures with Santreva-ATK Endovascular Revascularization Catheter

Santreva-ATK is the world’s first wire-free, external power-free, intraplaque chronic total occlusion (CTO) crossing and one-step vessel preparation platform for femoropopliteal arteries. – Atheroplasty represents a new era in endovascular revascularization of complex lesions in severely stenosed vessels, including CTOs – Now available in Europe; U.S. launch planned for October […]